FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912182261> ?p ?o ?g. }

• W2912182261 endingPage "872" @default.
• W2912182261 startingPage "864" @default.
• W2912182261 abstract "Abstract Background and Aims Ustekinumab, an anti-IL12/23p40 monoclonal antibody, has been approved for Crohn’s disease [CD]. Real-life data in CD patients receiving ustekinumab intravenously [IV] during induction, followed by subcutaneous [SC] maintenance, are lacking. We assessed efficacy of ustekinumab and studied exposure-response correlations. Methods We performed a prospective study in 86 CD patients predominantly refractory or intolerant to anti-tumour necrosis factor agents and/or vedolizumab. All received ustekinumab 6 mg/kg IV induction, with 90 mg SC every 8 weeks thereafter. Endoscopic response (50% decrease in Simple Endoscopic Score for CD [SES-CD] at Week 24), endoscopic remission [SES-CD ≤2], and clinical remission [daily stool frequency ≤2.8 and abdominal pain score ≤1] were assessed at weeks 4,8,16, and 24. Further serial analyses included patient-reported outcomes [PRO2], faecal calprotectin [fCal], and ustekinumab serum levels. Results SES-CD decreased from 11.5 [8.0–18.0] at baseline to 9.0 [6.0–16.0] at week [w]24 [p = 0.0009], but proportions of patients achieving endoscopic response [20.5%] or endoscopic remission [7.1%] were low. Clinical remission rates were 39.5% at w24. After IV induction, fCal dropped from baseline [1242.9 μg/g] to w4 [529.0 μg/g] and w8 [372.2 μg/g], but increased again by w16 [537.4 μg/g] and w24 [749.0 μg/g]. A clear exposure-response relationship was observed, both during induction and during maintenance therapy, with different thresholds depending on the targeted outcome. Conclusions In this cohort of refractory CD patients, ustekinumab showed good clinical remission rates but limited endoscopic remission after 24 weeks. Our data suggest that higher doses may be required to achieve better endoscopic outcomes." @default.
• W2912182261 created "2019-02-21" @default.
• W2912182261 creator A5019474609 @default.
• W2912182261 creator A5024846292 @default.
• W2912182261 creator A5029428855 @default.
• W2912182261 creator A5036654221 @default.
• W2912182261 creator A5045465014 @default.
• W2912182261 creator A5061164814 @default.
• W2912182261 creator A5062192511 @default.
• W2912182261 creator A5064462264 @default.
• W2912182261 creator A5071797672 @default.
• W2912182261 creator A5082317019 @default.
• W2912182261 creator A5090880326 @default.
• W2912182261 date "2019-02-08" @default.
• W2912182261 modified "2023-10-11" @default.
• W2912182261 title "Ustekinumab Exposure-outcome Analysis in Crohn’s Disease Only in Part Explains Limited Endoscopic Remission Rates" @default.
• W2912182261 cites W1911418949 @default.
• W2912182261 cites W1968358640 @default.
• W2912182261 cites W1972082388 @default.
• W2912182261 cites W2071427170 @default.
• W2912182261 cites W2085127303 @default.
• W2912182261 cites W2116956799 @default.
• W2912182261 cites W2149170290 @default.
• W2912182261 cites W2161723853 @default.
• W2912182261 cites W2168505126 @default.
• W2912182261 cites W2188248802 @default.
• W2912182261 cites W2331765344 @default.
• W2912182261 cites W2424311920 @default.
• W2912182261 cites W2553902775 @default.
• W2912182261 cites W2560051980 @default.
• W2912182261 cites W2586192851 @default.
• W2912182261 cites W2593531649 @default.
• W2912182261 cites W2598577802 @default.
• W2912182261 cites W2603226668 @default.
• W2912182261 cites W2604780989 @default.
• W2912182261 cites W2606398981 @default.
• W2912182261 cites W2621301955 @default.
• W2912182261 cites W2744879509 @default.
• W2912182261 cites W2786974934 @default.
• W2912182261 cites W2794023413 @default.
• W2912182261 cites W2794045318 @default.
• W2912182261 cites W2795429678 @default.
• W2912182261 cites W2826641198 @default.
• W2912182261 cites W2883220140 @default.
• W2912182261 cites W2884826108 @default.
• W2912182261 cites W2888061430 @default.
• W2912182261 cites W4233817719 @default.
• W2912182261 cites W4248269869 @default.
• W2912182261 doi "https://doi.org/10.1093/ecco-jcc/jjz008" @default.
• W2912182261 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30715258" @default.
• W2912182261 hasPublicationYear "2019" @default.
• W2912182261 type Work @default.
• W2912182261 sameAs 2912182261 @default.
• W2912182261 citedByCount "75" @default.
• W2912182261 countsByYear W29121822612019 @default.
• W2912182261 countsByYear W29121822612020 @default.
• W2912182261 countsByYear W29121822612021 @default.
• W2912182261 countsByYear W29121822612022 @default.
• W2912182261 countsByYear W29121822612023 @default.
• W2912182261 crossrefType "journal-article" @default.
• W2912182261 hasAuthorship W2912182261A5019474609 @default.
• W2912182261 hasAuthorship W2912182261A5024846292 @default.
• W2912182261 hasAuthorship W2912182261A5029428855 @default.
• W2912182261 hasAuthorship W2912182261A5036654221 @default.
• W2912182261 hasAuthorship W2912182261A5045465014 @default.
• W2912182261 hasAuthorship W2912182261A5061164814 @default.
• W2912182261 hasAuthorship W2912182261A5062192511 @default.
• W2912182261 hasAuthorship W2912182261A5064462264 @default.
• W2912182261 hasAuthorship W2912182261A5071797672 @default.
• W2912182261 hasAuthorship W2912182261A5082317019 @default.
• W2912182261 hasAuthorship W2912182261A5090880326 @default.
• W2912182261 hasBestOaLocation W29121822612 @default.
• W2912182261 hasConcept C121332964 @default.
• W2912182261 hasConcept C126322002 @default.
• W2912182261 hasConcept C141071460 @default.
• W2912182261 hasConcept C142424586 @default.
• W2912182261 hasConcept C2776207728 @default.
• W2912182261 hasConcept C2776694085 @default.
• W2912182261 hasConcept C2778283404 @default.
• W2912182261 hasConcept C2778975655 @default.
• W2912182261 hasConcept C2779134260 @default.
• W2912182261 hasConcept C2779280984 @default.
• W2912182261 hasConcept C2780132546 @default.
• W2912182261 hasConcept C2780955771 @default.
• W2912182261 hasConcept C71924100 @default.
• W2912182261 hasConcept C87355193 @default.
• W2912182261 hasConcept C90924648 @default.
• W2912182261 hasConceptScore W2912182261C121332964 @default.
• W2912182261 hasConceptScore W2912182261C126322002 @default.
• W2912182261 hasConceptScore W2912182261C141071460 @default.
• W2912182261 hasConceptScore W2912182261C142424586 @default.
• W2912182261 hasConceptScore W2912182261C2776207728 @default.
• W2912182261 hasConceptScore W2912182261C2776694085 @default.
• W2912182261 hasConceptScore W2912182261C2778283404 @default.
• W2912182261 hasConceptScore W2912182261C2778975655 @default.
• W2912182261 hasConceptScore W2912182261C2779134260 @default.
• W2912182261 hasConceptScore W2912182261C2779280984 @default.
• W2912182261 hasConceptScore W2912182261C2780132546 @default.

• next